Celldex Therapeutics Inc (NASDAQ:CLDX)

2.37
Delayed Data
As of Feb 23
 +0.01 / +0.42%
Today’s Change
2.20
Today|||52-Week Range
3.94
-16.55%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Celldex Therapeutics Inc have a median target of 9.00, with a high estimate of 10.00 and a low estimate of 3.50. The median estimate represents a +279.75% increase from the last price of 2.37.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Celldex Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.25
Sales
$1.6M
Reporting Date
TBD

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -23.57%
 
 
 
 
 
 
Growthannually 24.97%
 
 
 
 
 
 

Sales

Growthquarterly -58.82%
 
 
 
 
 
 
Growthannually 55.41%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.